Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Advisory Committees

November 19, 2010: Cellular, Tissue and Gene Therapies Advisory Committee Meeting Draft Agenda

Meeting #49, November 19, 2010
Hilton Hotel, Gaithersburg, MD


Open Session

8:30 a.m.

Call to Order and Opening Remarks
Matthew Allen, M.B. Vet Med, Ph.D., Acting Chair

Conflict of Interest Statement
Gail Dapolito, Designated Federal Official


Recognition of Committee Service

Topic: Testing of Replication Competent Retrovirus (RCR)/Lentivirus
(RCL) in Retroviral and Lentiviral Vector Based Gene Therapy Products

9:00FDA Presentations
Introduction and Overview of RCR/RCL Testing
10:00Guest Presentations
RCR/RCL Lot Release Testing for Retroviral and Lentiviral Vector Transduced Cells
12:30 p.m.Guest Presentations (Cont’d)
Accumulative RCR/RCL Lot Release Data of Final Transduced Cell Products from Clinical Studies: Challenges and Alternative Proposals
1:45Open Public Hearing
3:00Committee Discussion of Questions
5:00 p.m.Adjourn

Page Last Updated: 08/24/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English